Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health 2014-11, Vol.17 (7), p.A632-A632
Hauptverfasser: Obando, C.A, Desanvicente-Celis, Z, Gonzalez, L, Muschett, D, Gonzalez, F, Goldberg, P
Format: Artikel
Sprache:eng
Schlagworte:
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A632
container_issue 7
container_start_page A632
container_title Value in health
container_volume 17
creator Obando, C.A
Desanvicente-Celis, Z
Gonzalez, L
Muschett, D
Gonzalez, F
Goldberg, P
description
doi_str_mv 10.1016/j.jval.2014.08.2261
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790459125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1098301514041916</els_id><sourcerecordid>1790459125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2501-1d5e642ce414d1eeba5e6163b74960a4e5c3126f822fdbbfa7ed88ae91ea7b183</originalsourceid><addsrcrecordid>eNo9UsuO0zAUjRCIGQa-AAl5yYIU23FeG6Qq80IaRDUMa-vGuVFdkrjYTqG_y5fMDR1Y-Vo-r6vjJHkr-EpwUXzcrXYHGFaSC7Xi1UrKQjxLzkUuVarKLHtOM6-rNOMiP0tehbDjnBeZzF8mZ7KUXEpVnSd_GhdietX3aKI94IQhsPUEwzHYwFzP1q31ENG7CdnaYKSZPXiEOOIUWePGPXjs2C8bt6yBFoyN8BsHZicWt8jucT-3gzWL1AYmGOHD8rSBaIkfTrwvJBtImWANDeRn3ZTeI0WIQC4b78Jf4wYmg56EIbJbOCC7BjuQe3Ss2eLoyNHD_nhSvXRLXMryOnnRwxDwzdN5kXy_vnpobtO7rzefm_VdamTORSq6HAslDSqhOoHYAt1FkbWlqgsOCnOTCVn0lZR917Y9lNhVFWAtEMpWVNlF8v6ku_fu54wh6tEGg8MAE7o5aFHWXOW1kDlBsxPU0GrBY6_33o7gj1pwvZSrd3opVy_lal7ppVxivXsymNsRu_-cf20S4NMJgLTmwaLXZrCTNTD8wCOGnZs9VUtJdJCa62_L_1i-h1BciZp2fQT027vC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790459125</pqid></control><display><type>article</type><title>Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel</title><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Obando, C.A ; Desanvicente-Celis, Z ; Gonzalez, L ; Muschett, D ; Gonzalez, F ; Goldberg, P</creator><creatorcontrib>Obando, C.A ; Desanvicente-Celis, Z ; Gonzalez, L ; Muschett, D ; Gonzalez, F ; Goldberg, P</creatorcontrib><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2014.08.2261</identifier><identifier>PMID: 27202248</identifier><language>eng</language><publisher>United States</publisher><subject>Internal Medicine</subject><ispartof>Value in health, 2014-11, Vol.17 (7), p.A632-A632</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2501-1d5e642ce414d1eeba5e6163b74960a4e5c3126f822fdbbfa7ed88ae91ea7b183</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27202248$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Obando, C.A</creatorcontrib><creatorcontrib>Desanvicente-Celis, Z</creatorcontrib><creatorcontrib>Gonzalez, L</creatorcontrib><creatorcontrib>Muschett, D</creatorcontrib><creatorcontrib>Gonzalez, F</creatorcontrib><creatorcontrib>Goldberg, P</creatorcontrib><title>Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel</title><title>Value in health</title><addtitle>Value Health</addtitle><subject>Internal Medicine</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9UsuO0zAUjRCIGQa-AAl5yYIU23FeG6Qq80IaRDUMa-vGuVFdkrjYTqG_y5fMDR1Y-Vo-r6vjJHkr-EpwUXzcrXYHGFaSC7Xi1UrKQjxLzkUuVarKLHtOM6-rNOMiP0tehbDjnBeZzF8mZ7KUXEpVnSd_GhdietX3aKI94IQhsPUEwzHYwFzP1q31ENG7CdnaYKSZPXiEOOIUWePGPXjs2C8bt6yBFoyN8BsHZicWt8jucT-3gzWL1AYmGOHD8rSBaIkfTrwvJBtImWANDeRn3ZTeI0WIQC4b78Jf4wYmg56EIbJbOCC7BjuQe3Ss2eLoyNHD_nhSvXRLXMryOnnRwxDwzdN5kXy_vnpobtO7rzefm_VdamTORSq6HAslDSqhOoHYAt1FkbWlqgsOCnOTCVn0lZR917Y9lNhVFWAtEMpWVNlF8v6ku_fu54wh6tEGg8MAE7o5aFHWXOW1kDlBsxPU0GrBY6_33o7gj1pwvZSrd3opVy_lal7ppVxivXsymNsRu_-cf20S4NMJgLTmwaLXZrCTNTD8wCOGnZs9VUtJdJCa62_L_1i-h1BciZp2fQT027vC</recordid><startdate>201411</startdate><enddate>201411</enddate><creator>Obando, C.A</creator><creator>Desanvicente-Celis, Z</creator><creator>Gonzalez, L</creator><creator>Muschett, D</creator><creator>Gonzalez, F</creator><creator>Goldberg, P</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201411</creationdate><title>Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel</title><author>Obando, C.A ; Desanvicente-Celis, Z ; Gonzalez, L ; Muschett, D ; Gonzalez, F ; Goldberg, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2501-1d5e642ce414d1eeba5e6163b74960a4e5c3126f822fdbbfa7ed88ae91ea7b183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Obando, C.A</creatorcontrib><creatorcontrib>Desanvicente-Celis, Z</creatorcontrib><creatorcontrib>Gonzalez, L</creatorcontrib><creatorcontrib>Muschett, D</creatorcontrib><creatorcontrib>Gonzalez, F</creatorcontrib><creatorcontrib>Goldberg, P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Obando, C.A</au><au>Desanvicente-Celis, Z</au><au>Gonzalez, L</au><au>Muschett, D</au><au>Gonzalez, F</au><au>Goldberg, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2014-11</date><risdate>2014</risdate><volume>17</volume><issue>7</issue><spage>A632</spage><epage>A632</epage><pages>A632-A632</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><cop>United States</cop><pmid>27202248</pmid><doi>10.1016/j.jval.2014.08.2261</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1098-3015
ispartof Value in health, 2014-11, Vol.17 (7), p.A632-A632
issn 1098-3015
1524-4733
language eng
recordid cdi_proquest_miscellaneous_1790459125
source Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals
subjects Internal Medicine
title Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T01%3A23%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost-Effectiveness%20Analysis%20of%20Abiraterone%20Acetate%20Treatment%20Compared%20with%20Cabacitaxel%20in%20the%20Republic%20of%20Panama,%20in%20Patients%20with%20Metastatic%20Castration-Resistant%20Prostate%20Cancer%20that%20Have%20Failed%20to%20Chemotherapy%20with%20Docetaxel&rft.jtitle=Value%20in%20health&rft.au=Obando,%20C.A&rft.date=2014-11&rft.volume=17&rft.issue=7&rft.spage=A632&rft.epage=A632&rft.pages=A632-A632&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2014.08.2261&rft_dat=%3Cproquest_cross%3E1790459125%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1790459125&rft_id=info:pmid/27202248&rft_els_id=1_s2_0_S1098301514041916&rfr_iscdi=true